Product Description
Nabilone is used to treat nausea and vomiting caused by cancer chemotherapy in people who have already taken other medications to treat this type of nausea and vomiting without good results. Nabilone is in a class of medications called cannabinoids. (Sourced from: https://medlineplus.gov/druginfo/meds/a607048.html)
Mechanisms of Action: CB1 Agonist,CB2 Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Austria | Canada | Germany | Greece | Ireland | Israel | United Kingdom | United States
Approved Indications: None
Known Adverse Events: None
Company: NEMA Research
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: United States
Active Clinical Trial Count: 1
Highest Development Phases
Phase 2: Marijuana Abuse
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| CAN-002 | P2 |
Completed |
Marijuana Abuse |
2023-08-21 |